Nektar Therapeutics NKTR:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 09/23/22 EDT
3.14UNCH (UNCH)
Volume
9,530
Close
3.14quote price arrow down-0.08 (-2.48%)
Volume
1,654,098
52 week range
3.02 - 19.37
Loading...
  • Open3.16
  • Day High3.19
  • Day Low3.07
  • Prev Close3.22
  • 52 Week High19.37
  • 52 Week High Date09/27/21
  • 52 Week Low3.02
  • 52 Week Low Date06/13/22

Key Stats

  • Market Cap588.44M
  • Shares Out187.40M
  • 10 Day Average Volume2.20M
  • Dividend-
  • Dividend Yield-
  • Beta1.18
  • YTD % Change-76.76

KEY STATS

  • Open3.16
  • Day High3.19
  • Day Low3.07
  • Prev Close3.22
  • 52 Week High19.37
  • 52 Week High Date09/27/21
  • 52 Week Low3.02
  • 52 Week Low Date06/13/22
  • Market Cap588.44M
  • Shares Out187.40M
  • 10 Day Average Volume2.20M
  • Dividend-
  • Dividend Yield-
  • Beta1.18
  • YTD % Change-76.76

RATIOS/PROFITABILITY

  • EPS (TTM)-2.83
  • P/E (TTM)-1.11
  • Fwd P/E (NTM)-2.29
  • EBITDA (TTM)-375.077M
  • ROE (TTM)-76.97%
  • Revenue (TTM)96.34M
  • Gross Margin (TTM)77.26%
  • Net Margin (TTM)-544.77%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date11/02/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Nektar Therapeutics

 

Profile

MORE
Nektar Therapeutics is a research-based biopharmaceutical company, which is focused on discovering and developing medicines in areas of unmet medical need. The Company's research and development pipeline of new investigational drugs includes potential therapies for oncology, immunology and virology. In oncology, it is studying several immuno-oncology (I-O) drug candidates, including bempegaldesleukin, NKTR-255 and NKTR-262. In immunology, it is focused on addressing...
Robert Chess
Independent Chairman of the Board
Howard Robin
President, Chief Executive Officer, Director
Jillian Thomsen
Chief Financial Officer, Senior Vice President
Address
455 Mission Bay Blvd S
San Francisco, CA
94158-2158
United States

Top Peers

SYMBOLLASTCHG%CHG
KNSA
Kiniksa Pharmaceuticals Ltd
10.93-0.52-4.54%
PGEN
Precigen Inc
2.18-0.18-7.63%
MCRB
Seres Therapeutics Inc
5.89-0.14-2.32%
IMTX
Immatics NV
9.05UNCHUNCH
NSTG
NanoString Technologies Inc
13.01-0.11-0.84%